Evidence map›Paper›PMID 33352890›Full record

ArticleNutrients2020

Evaluation of Vitamin D Metabolism in Patients with Type 1 Diabetes Mellitus in the Setting of Cholecalciferol Treatment.

Alexandra Povaliaeva, Ekaterina Pigarova, Artem Zhukov, Viktor Bogdanov, Larisa Dzeranova, Olga Mel'nikova, Elena Pekareva, Natalya Malysheva, Vitaliy Ioutsi, Larisa Nikankina and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04844164 (Prospective Non-randomised Controlled Study of Vitamin D Metabolism in Patients With Endocrine Disorders), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04844164 phase1completednot on this map

Prospective Non-randomised Controlled Study of Vitamin D Metabolism in Patients With Endocrine Disorders (Acromegaly, Cushing's Disease, Primary Hyperparathyroidism, Diabetes Mellitus Type 1) Treated With Cholecalciferol Bolus Dose

TypeinterventionalSponsorEndocrinology Research Centre, MoscowRan2019 to 2021Enrolled261ConditionsPituitary ACTH Hypersecretion, Acromegaly, Diabetes Mellitus, Type 1, Primary HyperparathyroidismArmsCholecalciferol 15000 UNT/ML Oral Solution
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Impaired Vitamin D Metabolism in Hospitalized COVID-19 Patients.Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Alexandra PovaliaevaEndocrinology Research Centre, 117036 Moscow, Russia.ORCID 0000-0002-7634-5457
Ekaterina PigarovaEndocrinology Research Centre, 117036 Moscow, Russia.
Artem ZhukovEndocrinology Research Centre, 117036 Moscow, Russia.ORCID 0000-0002-2729-9386
Viktor BogdanovEndocrinology Research Centre, 117036 Moscow, Russia.ORCID 0000-0001-6377-9056
Larisa DzeranovaEndocrinology Research Centre, 117036 Moscow, Russia.
Olga Mel'nikovaEndocrinology Research Centre, 117036 Moscow, Russia.
Elena PekarevaEndocrinology Research Centre, 117036 Moscow, Russia.
Natalya MalyshevaEndocrinology Research Centre, 117036 Moscow, Russia.ORCID 0000-0001-7321-9052
Vitaliy IoutsiEndocrinology Research Centre, 117036 Moscow, Russia.
Larisa NikankinaEndocrinology Research Centre, 117036 Moscow, Russia.
Liudmila RozhinskayaEndocrinology Research Centre, 117036 Moscow, Russia.
Endocrinology Research Center · RU

Funding

Russian Science Foundation 19-15-00243
6 · The paper itself

Abstract

In this prospective controlled study, we examined 25 adults with adequately controlled (HbA1c level < 8.0%) type 1 diabetes mellitus (T1DM) and 49 conditionally healthy adults, intending to reveal the diversity of vitamin D metabolism in the setting of cholecalciferol intake at a therapeutic dose. All patients received a single dose (150,000 IU) of cholecalciferol aqueous solution orally. Laboratory assessments including serum vitamin D metabolites (25(OH)D

Indexed as

24,25-Dihydroxyvitamin D 325-Hydroxyvitamin D 2Administration, OralAdultCalcifediolCalcitriolCase-Control StudiesCholecalciferolDiabetes Mellitus, Type 1FemaleGlycated HemoglobinHumansMaleParathyroid HormoneProspective StudiesVitamin D24,25-Dihydroxyvitamin D 325-Hydroxyvitamin D 2CalcifediolCalcitriolCholecalciferolGC protein, humanGlycated Hemoglobinhemoglobin A1c protein, humanParathyroid HormoneVitamin DVitamin D-Binding Proteincholecalciferoltype 1 diabetes mellitusvitamin Dvitamin D-binding protein

Identifiers

PMID33352890
PMCPMC7767242
OpenAlexW3112984198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.